Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Stocks Close Higher Monday Ahead of CPI Data
Kyle O’Dell, founder & CEO of EdgeRock Wealth Management, joined Cheddar News to discuss Monday’s market trading session and what to look for in Tuesday's CPI report as Wall Street continues to digest the Fed's move last month.
Load More